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Abstract
Background: Evidence from animal studies indicates the importance of an interaction between the sympathetic nervous
system and the endothelium for cardiovascular regulation. However the interaction between these two systems remains
largely unexplored in humans. The aim of this study was to investigate whether directly recorded sympathetic
vasoconstrictor outflow is related to a surrogate marker of endothelial function in healthy individuals.
Methods and Results: In 10 healthy normotensive subjects (3 f/7 m), (age 37611 yrs), (BMI 2463 kg/m
2) direct recordings
of sympathetic action potentials to the muscle vascular bed (MSNA) were performed and endothelial function estimated
with the Reactive Hyperaemia- Peripheral Arterial Tonometry (RH-PAT) technique. Blood samples were taken and time spent
on leisure-time physical activities was estimated. In all subjects the rate between resting flow and the maximum flow, the
Reactive Hyperemic index (RH-PAT index), was within the normal range (1,9–3,3) and MSNA was as expected for age and
gender (13–44 burst/minute). RH-PAT index was inversely related to MSNA (r=20.8, p=0.005). RH-PAT index and MSNA
were reciprocally related to time (h/week) spent on physical activity (p=0.005 and p=0.006 respectively) and platelet
concentration (PLT) (p=0.02 and p=0.004 respectively).
Conclusions: Our results show that sympathetic nerve activity is related to a surrogate marker of endothelial function in
healthy normotensive individuals, indicating that sympathetic outflow may be modulated by changes in endothelial
function. In this study time spent on physical activity is identified as a predictor of sympathetic nerve activity and
endothelial function in a group of healthy individuals. The results are of importance in understanding mechanisms
underlying sympathetic activation in conditions associated with endothelial dysfunction and emphasise the importance of a
daily exercise routine for maintenance of cardiovascular health.
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Introduction
While the sympathetic nervous system plays a central role in the
regulation of the cardiovascular system the endothelium plays a
key role in the local regulation of peripheral vascular tone and
structure. As both systems play a crucial role in short- and long
term adjustments of the cardiovascular system both are heavily
involved in the development and prognosis of cardiovascular
events and disease [1] [2,3].
Evidence from animal studies indicates the importance of an
interaction between the sympathetic nervous system and the
endothelium for cardiovascular regulation [4].
Though such data from human studies is limited, independent
observations in previous studies may suggest a reciprocal
relationship between endothelial function and the activity of the
sympathetic nervous system. An acute increase in sympathetic
activity has been shown to cause a decrease in endothelial
function [5]. Men tend to have higher sympathetic outflow than
women in reproductive age, who in turn have higher endothelial
nitric oxide (NO) production [6]. Sympathetic nerve activity is
augmented in the early morning before waking, while endothelial
function has been reported to attenuate [7,8]. Beta adrenergic-
blockade treatment aimed at reducing sympathetic nervous
activity, raises endothelial function [9]. Aging is associated with
increased sympathetic outflow [10] and decreased endothelial
function [11].
Though these observations are not evidence of a causal
relationship, the number of independent observations makes
such a hypothesis feasible. Furthermore, hypertension, insulin
resistance, adult onset growth hormone (GH)-deficiency,
polycystic ovary syndrome (PCOS) and congestive heart failure
(CHF), are conditions coupled with severely decreased
endothelial function [12,13,14] and greatly increased sympa-
thetic nerve activity [1,15,16,17]. In these conditions, physical
activity thought to be protective against the development
of vascular disease, has been shown to have beneficial effects
on both sympathetic outflow and endothelial function
[18,19,20,21,22,23].
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9257Against this background, the aim of this study was to investigate
if directly recorded sympathetic vasoconstrictor outflow is related
to a surrogate marker of endothelial function, the RH-PAT index,
in physically active, normotensive, healthy individuals.
Results
Table 1 summarises the basic characteristics and laboratory
values of the study group. MSNA was as expected, lower in
females than males (p=0.01) and increased with age (p=0.05) in
this cohort of subjects [34] while the RH-PAT index was not
related to age and gender.
MSNA, RH-PAT Index and Physical Activity
Table 2 summarises the results of a simple correlation matrix
illustrating that MSNA was inversely related to the RH-PAT index
(r=20.8, p=0.005, figure 1), and time spent on physical activity
(h/wk) (r=20.79, p=0.006, figure 2a) and positively related to
PLT and EGF concentration (p=0.02 for both). All relationships
were independent of age and gender. MSNA was not related to
other measured parameters in this study.
The RH-PAT index was positively related to time spent on
physical activity (h/wk) (r=0.83, p=0.004, figure 2b) and
inversely related to PLT concentration (p=0.004), but not to
other parameters measured.
In addition to being related to MSNA and the PH-PAT index,
time spent on physical activity (h/wk) was inversely related to PLT
concentration (p=0.03).
In a multiple linear regression analyses (power=0.8), time spent
on physical activity (h/wk) and PLT concentration were able
to explain the relation between MSNA and the RH-PAT index,
but physical activity (h/wk) had a stronger impact than PLT
concentration (regression weights; 20.3 (p=0.5) and 0.1 (p=0.7),
respectively).
Discussion
The importance of an interaction between the sympathetic
nervous system and the endothelium for cardiovascular regulation
is becoming increasingly evident, but data from human studies is
limited.
This study demonstrates that in healthy individuals without
any evidence of vascular atherosclerosis, directly recorded
sympathetic nerve activity is inversely related to a surrogate
marker of endothelial function, the RH-PAT index. Further-
more, self-reported time spent on physical activity assessed in
hours per week, was inversely related to MSNA and positively
related to RH-PAT index, indicating that the more time spent
on physical activity the lower your sympathetic outflow and
better your endothelial function. Though correlations can not
serve as evidence of a causal relationship, the results are of
interest and render for further investigation into underlying
mechanisms.
Table 1. Basic characteristics of the 10 (7 M/3 F) subjects
shown in mean, SD and range.
Variable Mean SD Range
Age, years 37 11.3 24–61
Body mass index, kg/m2 24 2.7 20–30
Heart rate, beats/min 59 12 40–80
Systolic BP, mmHg 121 7.6 109–133
Diastolic BP, mmHg 70 6.5 62–81
Mean Arterial Pressure, mmHg 86 5.5 77–95
Microneurography and RH-PAT
MSNA, bursts/min 33 10.5 13–44
MSNA, bursts/100 heart beats 57 17.6 28–88
Reactive Hyperemic Index (%) 2.3 0.5 1.58–3.33
Blood samples
Triglycerides (mmol/L) 0.98 0.4 0.4–1.55
Apolipoprotein A (g/L) 1.26 0.15 1.07–1.55
Apolipoprotein B (g/L) 0.86 0.23 0.5–1.22
Cholesterol (mmol/L) 4.8 1.11 3.4–6.2
Low Density Lipoprotein (mmol/L) 99 50.4 0.00–175
High Density Lipoprotein (mmol/L) 1.48 0.28 1.0–1.84
Insulin-like Growth Factor-I (ug/L) 209 69.8 130–327
Epidermal growth factor (pg/ml) 57 24.7 30.5–118.8
Platelet concentration (610 g/L) 227 51.3 146–309
doi:10.1371/journal.pone.0009257.t001
Figure 1. Muscle sympathetic nerve activity (MSNA) expressed
as burst frequency (bursts/minute) and reactive hyperemic
index (%) in 10 healthy controls, r=20.8, p=0.005.
doi:10.1371/journal.pone.0009257.g001
Table 2. Simple correlation matrix showing associations
between Muscle Sympathetic Nerve Activity (MSNA), Reactive
Hyperemic Index (RHI), Platelet concentration (PLT), Epidermal
growth factor (EGF), Insulin-Like Growth Factor (IGF)-I, and
physical activity (PA) for the study group.
MSNA RHI PLT EGF IGF-I
RHI 20.80***
PLT 0.73* 20.85***
EGF 0.75* 20.45 0.58
IGF-I 20.50 0.49 20.45 20.36
PA 20.79** 0.83*** 20.72* 20.06 0.35
P-values are indicated as: *p#0.05; **p#0.01; ***p#0.005.
doi:10.1371/journal.pone.0009257.t002
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In this study physical activity is identified as an independent
predictor of sympathetic nerve activity and endothelial function in a
group of healthy individuals. Physical activity has been shown to
greatly improve endothelial function in both health and disease
[35,36] and to play a early protective role for cardiovascular health
[24]. The effects of physical exercise on sympathetic nerve activity
in healthy subjects have however yielded conflicting results, showing
both an increase and decrease in resting MSNA [37].
Exercise induces favourable gene expression in endothelial cells,
ie. nitric oxide (NO) synthase and extracellular superoxide
dismutase (SOD), which improves NO biological activity [38].
Bioavailability of NO has been proposed to be tonically involved
in the restraint of central sympathetic outflow [39,40,41] which is
in line with a previous finding from our group of an inverse
relation between plasma nitrate level and sympathetic nerve
activity in aging men [16]. Physical fitness improves endothelial
function in older men [11] by increasing bioavailability of vascular
NO and has beneficial effects on the age-related increase in
sympathetic outflow by decreasing sympathetic activity during
extended physical exercise [22]. This effect was recently
demonstrated by Gao and coworkers [42] to be associated with
upregulation of SOD expression in the central nervous system.
Reactive oxygen species (ROS), which decreases the bioavail-
ability of NO, plays a critical role in the development of
endothelial dysfunction [43] and has been shown to be involved
in activation of the sympathetic nervous system [44]. ROS is
chronically elevated in many conditions related to endothelial
dysfunction such as, atherosclerosis, type 2 diabetes mellitus,
hypertension and cardiac failure [45,46] which in turn are also
associated with increased sympathetic nerve activity. Endothelial
dysfunction crucially contributes to the reduced exercise capacity
in patients with congestive heart failure, with fundamental impact
on morbidity and mortality. Physical exercise has been shown to
reduce MSNA in heart failure [18] and to alter HRV in type 2
diabetes[21], an effect proposed to originate from a central effect
of training [22]. Furthermore, physical exercise increases NO
bioavailability, augments insulin sensitivity and decreases sympa-
thetic nerve activity in insulin resistant subjects [19]. It is possible
that in conditions associated with endothelial dysfunction
[12,13,14] [1,15,16] an impairment in the synthesis and/or
release of NO may contribute to the sustained sympathetic
activation seen in these conditions.
The measurement of digital RH-PAT was recently shown to be
a useful test of NO bioavailability and endothelial function in
healthy individuals [47]. It may therefore be speculated that the
beneficial effects of physical activity on sympathetic outflow and
the RH-PAT index in our study, could be related to augmented
NO bioavailability [40]. In this study platelet concentration was
also able to explain the relation between sympathetic outflow and
the RH-PAT index, though its impact was weaker than that of
time spent on physical activity. As endothelial derived NO is a
major endogenous modulator of platelet function, the relationships
seen between platelet concentration, MSNA and RH-PAT index
in this study may reflect the extent of NO bioavailability in our
subjects and support the notion that NO might be a possible
afferent mediator responsible for the relationships.
Sympathetic nerve activity tends to increase [10] and
endothelial function to decrease with advancing age [11]. An
age-related reduction in the activity of the somatotropic hormonal
(GH)/IGF-I) axis may be suggested as a plausible explanation as
this axis is involved in the regulation of central sympathetic
outflow [48] as well as in endothelial production of NO [49] and
stimulation of NO production in vascular smooth muscle cells. In
this study serum IGF-I was not significantly related to MSNA or
the RH-PAT index and can therefore not explain the relationships
observed.
Men tend to have higher sympathetic outflow than women. The
underlying mechanisms remain largely unclear [34], but evidence
from both human and animal studies indicate that sex hormones
may modify the synthesis/bioactivity of NO. Total NO production
is greater in women at reproductive age than in men [6] and
endothelial NO release is greater in blood vessels of female than
male rats [50]. We have recently shown that women with PCOS,
the most common endocrine cause of infertility in young women,
known to be associated with decreased endothelial function [51]
have severely increased sympathetic outflow. The increased
sympathetic nerve activity was shown to be due to the excessive
testosterone levels distinguishing the condition [17]. In this study,
total testosterone level was measured but was not related to
sympathetic nerve activity or the RH-PAT index.
In conclusion: the novel finding in this study is that in a group of
healthy subjects, sympathetic outflow is related to a surrogate
marker of endothelial function, the RH-PAT index, a relationship
Figure 2. Physical activity expressed as hours per week and a)
muscle sympathetic nerve activity (MSNA) expressed as burst
frequency (bursts/minute) and b) reactive hyperaemic index
(%) in 10 healthy controls, (r=20.79, p=0.006 and r=0.83,
p=0.004, respectively).
doi:10.1371/journal.pone.0009257.g002
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activity. The results lend support to the hypothesis of an
interaction between the sympathetic nervous system and endo-
thelium in cardiovascular regulation and emphasise the impor-
tance of a daily exercise routine for maintenance of cardiovascular
health.
Though the statistical correlation between MSNA and the RH-
PAT index in this study cannot serve as evidence for a causal
relationship between the systems, the results are of importance in
understanding mechanisms underlying increased sympathetic
outflow in conditions associated with decreased endothelial
function.
Limitations of the Study
A limitation to this study is the lack of identifying the specific
mechanisms responsible for the observed interesting phenomenon
and we can only speculate that a potential afferent candidate may
involve nitric oxide. A further limitation is that only healthy,
physically active, normotensive individuals were recruited and
studied. However, whether the present relationship between
sympathetic outflow and endothelial function also is evident in
healthy sedentary individuals as well as in conditions associated
with endothelial dysfunction awaits future studies.
As the RH-PAT probe is placed on the digit where there are no
muscles, it may be argued that the RH-score could reflect skin
sympathetic nerve activity (SSNA) rather than MSNA. As SSNA is
mainly involved in thermoregulation the RH-index would reflect
skin vascular physiology rather than systemic hemodynamics.
Interestingly, though skin vascular physiology cannot explain
systemic hemodynamics, both skin vasodilatation and flow
mediated vasodilatation were recently shown to be markedly
attenuated in the early morning hours in healthy subjects [7,52].
In this study, SSNA was obtained in five out of ten subjects, but no
clear relationship was found between this branch of the
sympathetic nervous system and the RH-index.
Methods
Subjects
Ten healthy non-athletic but physically active subjects (3
females/7 males) with a median age of 35 years (range 24–
61 yrs) and a body mass index (BMI) of 23 kg/m
2 (range 20–30),
free from medication and without any former history of
cardiovascular disease or diabetes mellitus, were recruited to the
study. A written informed consent was attained from all the
participants in this study, which was approved by the local ethics
committee at Sahlgrenska University Hospital, Gothenburg,
Sweden.
Study Design
On the first visit reactive hyperemia arterial tonometry (RH-
PAT) measurements were performed. On the second visit and
after an overnight fast blood samples were taken for triglycerides,
cholesterol, apolipoprotein A1 and B, epidermal growth factor
(EGF), insulin-like growth factor (IGF)-I, total testosterone and
Thyrotrophic stimulating hormone (TSH). On the third visit, body
height and weight, resting blood pressure and a microneuro-
graphic recording of muscle sympathetic nerve activity (MSNA)
were performed. Body weight was measured to the nearest 0.1 kg,
and body height was measured barefoot to the nearest 0.01 m.
The body mass score (BMI) was calculated as body weight in
kilograms divided by height in meters squared. Systolic (SBP) and
diastolic (DBP) blood pressure was measured using a calibrated
sphygmomanometer to the nearest 5 mmHg during 15 minutes of
supine rest. Average blood pressure values were derived from 3
consecutive measurements. Mean arterial pressure (MAP) was
calculated by the formula MAP = DBP + (SBP-DBP)/3.
Assessment of Physical Activity History
All participants reported the average amount of time spent
weekly on high-intensity aerobic training (including jogging,
swimming, participation in aerobics, football, etc.) and daily
activity (including walking or bicycling to work). Total self-
reported physical activity, recently demonstrated to be positively
correlated to steady-state V ? O2 maxc in healthy young individuals
[24], was calculated as the sum of time spent weekly on high-
intensity aerobic training and daily activity expressed as hours per
week (h/wk).
Biochemical Measurements
All biochemical analyzes were performed using commercially
available kits, according to the Manufacturer’s protocols. Serum
triglycerides (TG), cholesterol, low (LDL)- and high density
lipoprotein (HDL)-cholesterol and plasma glucose was measured
with enzymathic photometric method, 37uC (TG, Roche/Hitachi,
CHOL, Roche/Hitachi, HDL-C 2
nd generation, Roche/Hitachi,
Roche Diagnostics, GmbH, Mannheim, Germany). The assays
were measured on Cobas mira analyzer (Hoffman- La Roche &
Co., Basle, Switzerland).
The Apolipoprotein A1 and B concentrations were measured
with turbid metric technique, using polyclonal rabbit anti-human
antibodies (Q 0496 and Q 0497, Daco Cytomation, Glostrup,
Denmark). Epidermal growth factor (EGF) was measured using
Randox Protein Chip technology [25]. Serum total testosterone
was measured by competitive immunochemistry with chemolumi-
niscence technology (ADVIA CentaurH TSTO Ready PackH
primary reagens, Bayer Health Care LLC, Tarrytown, NY, US).
Serum Insulin-like growth factor (IGF)-1 was measured with
immunochemoluminiscence technology (Immulite 2500 IG1,
Euro/DPC, UK). Thyroid-stimulating hormone (TSH) was
measured with electrochemiluminescence immuno assay (ECLIA),
37uC (TSH Thyrotropin, Roche Diagnostics GmbH, Mannheim,
Germany).
Reactive Hyperemia Arterial Tonometry (RH-PAT)
Endothelial function was estimated by using the Endo-PAT
device (Itamar Medical Ltd., Caesarea, Israel), a noninvasive
technology that captures a beat-to-beat plethysmographic record-
ing of the finger arterial pulse wave amplitude (PWA) with
pneumatic probes, detecting the peripheral arterial tone. Periph-
eral arterial tonometry (PAT) was assessed in response to reactive
hyperemia. Subjects were in a comfortable sitting position with
hands at heart level. Digit probes were placed on both index
fingers and a continuous recording of pulsatile blood volume
response from both hands was initiated. A blood pressure cuff was
placed on the study arm, while the contra-lateral arm served as
control. The subjects were allowed to rest for fifteen minutes
before a five minute occlusion of the brachial artery was
performed by inflating the blood pressure cuff to 60 mmHg
above systolic pressure. Following the occlusion, the cuff was
deflated to allow flow-mediated reactive hyperemia (RH) while the
PAT recording was continued. Pulse wave amplitudes were
recorded for 5 minutes after the cuff was deflated. As a measure
of extent of RH, the RH-PAT index was calculated as the ration of
the average amplitude of the PAT signal over a 1 minute time
interval starting one minute after cuff deflation divided by the
average amplitude of the PAT signal over a 3.5 minute time period
before cuff inflation (baseline) [26]. The RH-PAT index values
SNS and Endothelial Function
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from the contralateral finger to correct for changes in systemic
vascular tone. The RH-PAT index was recently shown to serve as
a surrogate marker of endothelial dysfunction in children with type
1 diabetes [27].
Since the ITAMAR method is relatively user-independent and
all the measurements and calculations were performed in an
automatic way by means of the software, the technical reproduc-
ibility is high [28].
Microneurography
Direct recordings of multiunit efferent postganglionic muscle
sympathetic nerve activity (MSNA) were obtained with a tungsten
microelectrode with a tip diameter of a few microns inserted into a
muscle fascicle of the peroneal nerve, posterior to the fibular head.
A low impedance reference electrode was inserted subcutaneously
a few centimetres away. When a muscle nerve fascicle had been
identified, small electrode adjustments were made until a site was
found in which spontaneous, pulse-synchronous bursts of neural
activity could be recorded. Details of the nerve recording
technique and criteria for MSNA have been reported previously
[29]. Bursts identified by inspection of the mean voltage
neurogram were expressed as burst frequency (bursts per min)
and burst incidence (bursts per 100 heartbeats). The nerve
recordings were assigned a code and analysed blinded.
During the microneurographic recording, finger arterial blood
pressure was measured non-invasively by the volume-clamp
method, (Finapress 2300, Ohmeda, Louisville, USA) [30], heart
rate was monitored via ECG-chest electrodes and respiration via a
strain-gage strapped around the waist.
MSNA consists of baroreceptor reflex controlled vasoconstrictor
impulses to the muscle vascular bed, involved in dynamic blood
pressure regulation. Although MSNA only represents one
subdivision of the sympathetic nervous system, at rest it correlates
well with a global measure of sympathetic nerve activity such as
total body norepinephrine spillover, and with regional (heart and
kidney) norepinephrine spillover [31,32].
Though MSNA differs between different individuals, it has been
shown to have strong intra-individual reproducibility over many
years, which makes it possible to monitor long-term changes in
MSNA, both in disease and therapeutic interventions [10,33].
Statistics
Statistical analysis was performed using STATISTICA 7 for
windows (StatSoft, Inc., Tulsa, OK). Results are presented as the
mean and SD. Correlations were examined by calculating the
Pearson linear correlation coefficient and a multivariate analysis
model was used to adjust for age and gender. A power value $0.8
was considered acceptable. A p-value #0.05 was considered
statistically significant.
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